132 related articles for article (PubMed ID: 30679163)
1. LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation.
Huang C; Li Y; Li Z; Xu Y; Li N; Ge Y; Dong J; Chang A; Zhao T; Wang X; Wang H; Yang S; Xie K; Hao J; Ren H
Clin Cancer Res; 2019 Jul; 25(13):4091-4103. PubMed ID: 30679163
[TBL] [Abstract][Full Text] [Related]
2. Multiscale genetic architecture of donor-recipient differences reveals intronic LIMS1 mismatches associated with kidney transplant survival.
Sun Z; Zhang Z; Banu K; Gibson IW; Colvin RB; Yi Z; Zhang W; De Kumar B; Reghuvaran A; Pell J; Manes TD; Djamali A; Gallon L; O'Connell PJ; He JC; Pober JS; Heeger PS; Menon MC
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37676733
[TBL] [Abstract][Full Text] [Related]
3. CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia.
Zhou Q; Huang W; Xiong J; Guo B; Wang X; Guo J
Cell Death Dis; 2023 Oct; 14(10):658. PubMed ID: 37813876
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α and adaptor protein LIM and senescent cell antigen-like domains protein 1 axis promotes tubulointerstitial fibrosis by interacting with vimentin in angiotensin II-induced hypertension.
Ni WJ; Li ZL; Wen XL; Ji JL; Liu H; Yin Q; Jiang LY; Zhang YL; Wen Y; Tang TT; Jiang W; Lv LL; Gan WH; Liu BC; Wang B
Br J Pharmacol; 2024 May; ():. PubMed ID: 38698737
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells in kidney transplant recipients with LIMS1 rs893403 risk genotype.
Mirioglu S; Kiran B; Lentine KL; Edwards JC; Caliskan Y
Clin Transplant; 2024 Apr; 38(4):e15293. PubMed ID: 38545889
[No Abstract] [Full Text] [Related]
6. Ku80 promotes melanoma growth and regulates antitumor effect of melatonin by targeting HIF1-α dependent PDK-1 signaling pathway.
Liu T; Jin L; Chen M; Zheng Z; Lu W; Fan W; Li L; Zheng F; Zhu Q; Qiu H; Liu J; Chen M; Tian C; Hu Z; Zhang C; Luo M; Li J; Kang T; Yang L; Li Y; Deng W
Redox Biol; 2019 Jul; 25():101197. PubMed ID: 31023624
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA.
Li Y; Wang S; Li G; Gao C; Cui Z; Cong M; Hu J; Zhang M; Jin X; Sun H; Kong D
Cancer Med; 2024 Apr; 13(7):e7129. PubMed ID: 38618967
[TBL] [Abstract][Full Text] [Related]
8. Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma.
Zhao T; Jiang T; Li X; Chang S; Sun Q; Kong F; Kong X; Wei F; He J; Hao J; Xie K
Clin Cancer Res; 2023 Dec; 29(24):5183-5195. PubMed ID: 37819952
[TBL] [Abstract][Full Text] [Related]
9. The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade.
Cui Y; Sun Y; Li D; Zhang Y; Zhang Y; Cao D; Cao X
Front Cell Dev Biol; 2023; 11():1275543. PubMed ID: 38020920
[TBL] [Abstract][Full Text] [Related]
10. Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma.
Saggese P; Pandey A; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Weisz A; Dubinett SM; Scafoglio C
bioRxiv; 2023 Feb; ():. PubMed ID: 36778362
[TBL] [Abstract][Full Text] [Related]
11. CYP3A5 unexpectedly regulates glucose metabolism through the AKT-TXNIP-GLUT1 axis in pancreatic cancer.
Shao M; Pan Q; Tan H; Wu J; Lee HW; Huber AD; Wright WC; Cho JH; Yu J; Peng J; Chen T
Genes Dis; 2024 Jul; 11(4):101079. PubMed ID: 38560501
[TBL] [Abstract][Full Text] [Related]
12. Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma.
Saggese P; Pandey A; Alcaraz M; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Shirihai OS; Weisz A; Dubinett SM; Scafoglio C
Cancer Res; 2024 Jan; 84(2):305-327. PubMed ID: 37934116
[TBL] [Abstract][Full Text] [Related]
13. m
Wang CR; Gong JH; Zhao ZB; Zhu Q; Shu B; Hu JJ; Cai D; Liu XY; Dai X; Qiu C; Gong JP; Zhong GC
Cell Death Differ; 2024 May; ():. PubMed ID: 38762597
[TBL] [Abstract][Full Text] [Related]
14. AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments.
Zhang W; Cao L; Yang J; Zhang S; Zhao J; Shi Z; Liao K; Wang H; Chen B; Qian Z; Xu H; Wu L; Liu H; Wang H; Ma C; Qiu Y; Ge J; Chen J; Lin Y
J Clin Invest; 2023 Nov; 134(3):. PubMed ID: 37988165
[TBL] [Abstract][Full Text] [Related]
15. Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma.
Liu J; Jiang W; Zhao K; Wang H; Zhou T; Bai W; Wang X; Zhao T; Huang C; Gao S; Qin T; Yu W; Yang B; Li X; Fu D; Tan W; Yang S; Ren H; Hao J
J Exp Med; 2019 Mar; 216(3):656-673. PubMed ID: 30733283
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Wang X; Li X; Wei X; Jiang H; Lan C; Yang S; Wang H; Yang Y; Tian C; Xu Z; Zhang J; Hao J; Ren H
Signal Transduct Target Ther; 2020 Apr; 5(1):38. PubMed ID: 32300119
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma.
Wang H; Jia R; Zhao T; Li X; Lang M; Lan C; Wang H; Li Z; Zhou B; Wu L; Sun Y; Wang X; Ren H; Hao J
Cancer Lett; 2019 Jul; 453():10-20. PubMed ID: 30922919
[TBL] [Abstract][Full Text] [Related]
18. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer.
Zhao T; Jin F; Xiao D; Wang H; Huang C; Wang X; Gao S; Liu J; Yang S; Hao J
Theranostics; 2020; 10(9):4088-4100. PubMed ID: 32226541
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.
Lin S; Huang C; Sun J; Bollt O; Wang X; Martine E; Kang J; Taylor MD; Fang B; Singh PK; Koomen J; Hao J; Yang S
EMBO Mol Med; 2019 Dec; 11(12):e10849. PubMed ID: 31633874
[TBL] [Abstract][Full Text] [Related]
20. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
Zhou T; Liu J; Xie Y; Yuan S; Guo Y; Bai W; Zhao K; Jiang W; Wang H; Wang H; Zhao T; Huang C; Gao S; Wang X; Yang S; Hao J
Gut; 2022 Feb; 71(2):357-371. PubMed ID: 33674341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
